A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/30 (2006.01) A61K 31/70 (2006.01) A61K 39/39 (2006.01) A61K 45/06 (2006.01) A61P 37/04 (2006.01)
Patent
CA 2439802
The invention provides the use of a physiologically tolerable zinc compound for the manufacture of a medicament for use in a method of treatment of an animal to generate a mucosal immune response therein to an antigen, which method comprises administering to said animal a said physiologically tolerable zinc compound and a said antigen whereby to generate said response, preferably by bringing said zinc compound and said antigen into contact with a mucosal surface in said animal.
L'invention concerne l'utilisation d'un composé de zinc physiologiquement acceptable dans la préparation d'un médicament destiné au traitement d'un animal visant à générer une réponse immunitaire des muqueuses à un antigène. Ce mode de traitement consiste à administrer à l'animal ce composé de zinc physiologiquement acceptable et cet antigène pour générer ladite réponse, de préférence en mettant le composé et l'antigène en contact avec la surface d'une muqueuse de l'animal.
Grewal Harleen
Sommerfelt Halvor
Fetherstonhaugh & Co.
Forinnova As
LandOfFree
Immune response potentiation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immune response potentiation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune response potentiation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2023137